Dual targeting of RANKL/RANK pathway and HER-2 as a novel treatment strategy in HER-2 positive (1) breast carcinomas (BC)-MedSci.cn

Dual targeting of RANKL/RANK pathway and HER-2 as a novel treatment strategy in HER-2 positive (1) breast carcinomas (BC)

Zoi, I; Xingi, E; Thomaidou, D; Papavassiliou, AG; Karamouzis, MV

ANNALS OF ONCOLOGY, 2019; 30 ():

科室
- - 订阅+
  - 更多科室
工具
服务